IP Library Granted Patent US 9,551,644
Granted Patent B2
US 9,551,644 · App. 14/328,755 · Granted Jan 24, 2017

Methods and apparatus for real-time detection and clearing of a clog

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,551,644
App. No.
14/328,755
Granted
Jan 24, 2017
Kind
B2
Abstract

A flow cytometer apparatus and methods for detecting and clearing a clog therein are disclosed. An example method for detecting a clog may include (i) detecting, via a fault detection system of a flow cytometer, a first plurality of events associated with a first aliquot from a first sample well, (ii) determining a count of the first plurality of events associated with the first aliquot, (iii) determining whether the count of the first plurality of events is below a minimum count tolerance and (iv) (a) if the count of the first plurality of events is below the minimum count tolerance, then determining that the flow cytometer has a clog, (b) if the count of the first plurality of events is equal to or above the minimum count tolerance, then detecting a second plurality of events associated with a second aliquot from a second sample well.

Claims (92)

1. A method, comprising:

detecting, via a fault detection system of a flow cytometer, a first plurality of events associated with a first aliquot from a first sample well;

determining, via the fault detection system, a count of the first plurality of events associated with the first aliquot;

determining, via the fault detection system, whether the count of the first plurality of events is below a minimum count tolerance; and

if the count of the first plurality of events is below the minimum count tolerance, then determining, via the fault detection system, that the flow cytometer has a clog;

if the count of the first plurality of events is equal to or above the minimum count tolerance, then detecting, via the fault detection system, a second plurality of events associated with a second aliquot from a second sample well.

2. The method of claim 1 , further comprising:

determining, via the fault detection system, a count of the second plurality of events;

determining, via the fault detection system, whether the count of the second plurality of events is below a minimum count tolerance; and

if the count of the second plurality of events is below the minimum count tolerance, then determining, via the fault detection system, that the flow cytometer has a clog;

if the count of the second plurality of events is equal to or above the minimum count tolerance, then detecting, via the fault detection system, a third plurality of events associated with a third aliquot from a third sample well of the flow cytometer.

3. The method of claim 2 , wherein the first aliquot comprises a plurality of marker particles, wherein the first plurality of counts corresponds to the plurality of marker particles of the first aliquot, wherein the second aliquot comprises a plurality of particles of interest, wherein the second plurality of counts corresponds to the plurality of particles of interest, wherein the third aliquot comprises a plurality of marker particles and wherein a third plurality of counts corresponds to the plurality of marker particles of the third aliquot.

4. The method of claim 3 , further comprising:

determining, via the fault detection system, a beginning of a count interval for the second aliquot;

determining, via the fault detection system, an end of the count interval for the second aliquot;

detecting, via the fault detection system, the plurality of events associated with the second aliquot during the count interval.

5. The method of claim 4 , wherein determining a beginning of a count interval for the second aliquot comprises

determining, via the fault detection system, data corresponding to a first histogram, wherein the first histogram is based upon the first plurality of events detected for the plurality of marker particles of the first aliquot over time; and

determining, via the fault detection system, a first time gate and a second time gate, wherein the first time gate corresponds to an earliest detected event in the first histogram, wherein the second time gate corresponds to a latest detected event in the first histogram, and wherein the second time gate is the beginning of the count interval.

6. The method of claim 4 , wherein determining an end of the count interval for the second aliquot comprises:

determining, via the fault detection system, data corresponding to a second histogram, wherein the second histogram is based upon the third plurality of events detected for the plurality of marker particles of the third aliquot over time; and

determining, via the fault detection system, a third time gate and a fourth time gate, wherein the third time gate corresponds to an earliest detected event in the second histogram, wherein the fourth time gate corresponds to a latest detected event in the second histogram and wherein the third time gate is the end of the count interval.

7. The method of claim 6 , wherein the fourth time gate is the beginning of a second count interval for a fourth aliquot.

8. The method of claim 2 , further comprising:

detecting, via the fault detection system, a fourth plurality of events associated with a fourth aliquot from a fourth sample well of the flow cytometer;

determining, via the fault detection system, a count of the fourth plurality of events;

determining, via the fault detection system, whether the count of the fourth plurality of events is below a minimum count tolerance;

if the count of the fourth plurality of events is below the minimum count tolerance, then

determining, via the fault detection system, whether the counts of the first, second and third plurality of events were dropped over time; and

if the counts of the first, second and third plurality of events dropped over time, then

determining, via the fault detection system, that the flow cytometer has a clog; and

pausing, via the fault detection system, a sampling operation of the flow cytometer; and

if the counts of the first, second and third plurality of events did not drop over time, then continuing the sampling operation of the flow cytometer for at least one more aliquot.

9. The method of claim 1 , wherein the first aliquot comprises a plurality of particles of interest and wherein the first plurality of counts corresponds to the plurality of particles of interest.

10. The method of claim 9 , further comprising:

before determining whether the count of the first plurality of events is below a minimum count tolerance, detecting, via the fault detection system, at least 1500 total events from one or more aliquots of samples from one or more sample wells.

11. The method of claim 1 , further comprising:

determining, via the fault detection system, whether the count of the first plurality of events is above a maximum count tolerance; and

if the count of the first plurality of events is above a maximum count tolerance, then

determining, via the fault detection system, that there is a system anomaly in the flow cytometer; and

pausing a sampling operation of the flow cytometer;

if the count of the first plurality of events is equal to or below a maximum count tolerance, then detecting, via the fault detection system, the second plurality of events associated with the second aliquot from the second sample well of the flow cytometer.

12. The method of claim 1 , wherein determining, via the fault detection system, that the flow cytometer has a clog comprises: detecting, via the fault detection system, at least one more plurality of events associated with a subsequent aliquot in a fluidic pathway of the flow cytometer;

determining, via the fault detection system, whether the count of the at least one more plurality of events is below the minimum count tolerance;

if the count of the at least one more plurality of events is below the minimum count tolerance, then pausing, via the fault detection system, a sampling operation of the flow cytometer; and

if the count of the first plurality of events is equal to or above the minimum count tolerance, then continuing the sampling operation of the flow cytometer.

13. The method of claim 1 ,

wherein the flow cytometer comprises (a) a flow cell having a first end and a second end, (b) a sample fluidic pathway having a first end and a second end, wherein the second end of the sample fluidic pathway is coupled to the first end of the flow cell, (c) a sample probe coupled to the first end of the sample fluidic pathway, (d) a sample pump in fluid communication with the sample fluidic pathway, (e) a waste line having a first end and a second end, wherein the first end of the waste line is coupled to the flow cell and (f) a waste pump in fluid communication with the waste line;

in response to determining that the flow cytometer has a clog, activating the waste pump, thereby applying negative pressure to one or more of a waste line, a flow cell and a sample fluidic pathway;

activating, via the flow cytometer, the sample pump; and

cycling, via the flow cytometer, the sample probe into and out of a decontamination solution reservoir and driving a decontamination fluid, via the sample pump, through one or more of the flow cell, the sample fluidic pathway and the waste line, thereby clearing a clog.

14. The method of claim 13 , further comprising:

cycling, via the flow cytometer, the sample probe into and out of a cleaning solution reservoir; and

driving a cleaning fluid, via the sample pump, through one or more of the flow cell, the sample fluidic pathway or the waste line, thereby cleaning away the decontamination fluid.

15. The method of claim 14 , further comprising:

cycling the sample probe into and out of a cell-compatible fluid reservoir; and

driving a cell-compatible fluid, via the sample pump, through one or more of the waste line, the flow cell and the sample fluidic pathway, thereby removing any remaining cleaning fluid.

16. The method of claim 13 , further comprising:

providing a sheath fluidic pathway coupled to the first end of the flow cell and a sheath pump in fluid communication with the sheath fluidic pathway;

activating, via the flow cytometer, the sheath pump; and

driving a sheath fluid, via the sheath pump, through one or more of the sheath fluidic pathway, the flow cell and the waste line.

17. The method of claim 13 , further comprising:

during the cycling of the sample probe into and out of the decontamination solution reservoir, pumping a plurality of decontamination fluid samples separated by air samples through the sample fluidic pathway.

18. The method of claim 13 , wherein cycling the sample probe into and out of the decontamination solution reservoir occurs for a period of time ranging from about two minutes to about five minutes.

19. The method of claim 13 , further comprising:

during the cycling the sample probe into and out of the cleaning solution reservoir, pumping a plurality of cleaning fluid samples separated by air samples through at least the sample fluidic pathway.

20. The method of claim 13 , wherein cycling the sample probe into and out of the cleaning solution reservoir occurs for a period of time ranging from about two minutes to about five minutes.

21. The method of claim 13 , further comprising:

during the cycling of the sample probe into and out of the cell-compatible fluid reservoir, pumping a plurality of cell-compatible fluid samples separated by air samples through at least the sample fluidic pathway.

22. The method of claim 13 , wherein cycling the sample probe into and out of the cleaning solution reservoir occurs for a period of time ranging from about two minutes to about five minutes.

23. The method of claim 13 , further comprising:

prior to activating the waste pump, ceasing a sampling operation and a data acquisition operation.

24. The method of claim 13 , further comprising:

providing a three-port valve coupled to the waste line between the flow cell and the waste pump, wherein the three-port valve has a first port, a second port and a third port, wherein the first port of the three-port valve is arranged in series with the second port of the three-port valve such that the first-port is arranged closer to the flow cell than the second port, and wherein the third port of the three-port valve is configured to communicate with atmosphere; and

wherein cycling the sample probe into and out of the decontamination solution reservoir comprises:

(a) operating the flow cytometer system in a forward mode;

(b) deactivating the waste pump and the sample pump;

(c) holding a plurality of decontamination fluid samples separated by air samples in at least the sample fluidic pathway;

(d) closing the second port of the three-port valve and opening the third port of the three-port valve;

(e) operating the sample pump in a reverse-mode and flowing the plurality of decontamination fluid samples in reverse through at least the sample fluidic pathway.

25. The method of claim 24 , wherein cycling the sample probe into and out of the cleaning solution reservoir comprises:

(a) operating the flow cytometer system in the forward mode;

(b) deactivating the waste pump and the sample pump;

(c) holding a plurality of cleaning fluid samples separated by air samples in the sample fluidic pathway;

(d) closing the second port of the three-port valve and opening the third port of the three-port valve; and

(e) operating the sample pump in the reverse-mode and flowing the plurality of decontamination fluid samples in reverse through at least the sample fluidic pathway.

26. The method of claim 25 , wherein cycling the sample probe into and out of the cell-compatible fluid reservoir comprises:

(a) activating the sheath pump; and

(b) operating the flow cytometer system in the forward mode.

27. The method of claim 13 , wherein the sample probe is positioned over a back flush waste fluid reservoir when the sample pump is operating in a reverse-mode.

28. The method of claim 1 , wherein the first plurality of events comprises a plurality of events related to fluorescence of a plurality of particles in the first aliquot.

29. The method of claim 28 , wherein the plurality of particles in the first aliquot are configured to fluoresce in the presence of light of a predetermined frequency, wherein the flow cytometer comprises a laser configured to emit light of the predetermined frequency, wherein the flow cytometer is configured to shine light emitted from the laser on the plurality of particles, and wherein detecting the first plurality of events comprises detecting an event related to fluorescence of the plurality of particles.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE STATE/COUNTRY PREVIOUSLY RECORDED AT REEL: 059280 FRAME: 0575. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER . Recorded Mar 31, 2022
From: ESSEN INSTRUMENTS, INC.
To: SARTORIUS BIOANALYTICAL INSTRUMENTS, INC.
Reel/Frame 059567/0690 →
MERGER Recorded Mar 16, 2022
From: ESSEN INSTRUMENTS, INC.
To: SARTORIUS BIOANALYTICAL INSTRUMENTS, INC.
Reel/Frame 059280/0575 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2020
From: INTELLICYT CORPORATION
To: ESSEN INSTRUMENTS, INC. D/B/A ESSEN BIOSCIENCE, INC.
Reel/Frame 054031/0847 →
MERGER AND CHANGE OF NAME Recorded Feb 14, 2019
From: INTELLICYT CORPORATION; ESSEN INSTRUMENTS, INC. D/B/A ESSEN BIOSCIENCE, INC.
To: ESSEN INSTRUMENTS, INC. D/B/A ESSEN BIOSCIENCE, INC.
Reel/Frame 048336/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2019
From: INTELLICYT
To: INTELLICYT CORPORATION
Reel/Frame 048319/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2014
From: KENNINGTON, AARON B.
To: INTELLICYT
Reel/Frame 033753/0390 →